Clinical Trial Update: A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007) [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update discusses Calderasib (MK-1084) in combination with other treatments for non-small cell lung cancer (MK-1084-007/KANDLELIT-007…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Calderasib (MK-1084)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: RECRUITING